Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dag, Ilkiz M."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Saydam, Güray, Haznedaroglu, Ibrahim Celalettin, Kaynar, Leylagul, Yavuz, Akif S., Ali, Ridvan, Guvenc, Birol, Akay, Olga M., Baslar, Zafer, Ozbek, Ugur, Sonmez, Mehmet, Aydin, Demet, Pehlivan, Mustafa, Undar, Bulent, Dagdas, Simten, Ayyildiz, Orhan, Akkaynak, Diyar Z., Dag, Ilkiz M., Ilhan, Osman
WOS: 000384401200003
PubMed ID: 27501474
Objective: Nilotinib is a BCR-ABL1 tyrosine kinase inhibitor approved for the treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP). This study was the first prospective evalu
PubMed ID: 27501474
Objective: Nilotinib is a BCR-ABL1 tyrosine kinase inhibitor approved for the treatment of patients with chronic myeloid leukemia in chronic phase (CML-CP). This study was the first prospective evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::f43fad7d2a54b965c4bf7c78829c86a5
https://hdl.handle.net/11454/33460
https://hdl.handle.net/11454/33460
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Saydam, Guray *, Haznedaroglu, Ibrahim C. *, Kaynar, Leylagul *, Yavuz, Akif S., Ali, Ridvan *, Guvenc, Birol *, Akay, Olga M. *, Baslar, Zafer *, Ozbek, Ugur *, Sonmez, Mehmet *, Aydin, Demet *, Pehlivan, Mustafa *, Undar, Bulent *, Dagdas, Simten *, Ayyildiz, Orhan M. *, Akkaynak, Diyar Z. *, Dag, Ilkiz M. *, Ilhan, Osman *
Publikováno v:
In Blood 15 November 2013 122(21):2742-2742
Autor:
Saydam G; a Department of Internal Medicine , Ege University Medical Faculty Hospital , Izmir , Turkey., Haznedaroglu IC; b Department of Internal Medicine , Hacettepe University Medical Faculty Hospital , Ankara , Turkey., Kaynar L; c Hematology Division , Erciyes University Medical Faculty Hospital , Kayseri , Turkey., Yavuz AS; d Department of Internal Medicine , Istanbul University Istanbul Medical Faculty , Istanbul , Turkey., Ali R; e Department of Internal Medicine , Uludag University Medical Faculty , Bursa , Turkey., Guvenc B; f Department of Internal Medicine , Cukurova University Medical Faculty Hospital , Adana , Turkey., Akay OM; g Department of Internal Medicine , Eskisehir Osmangazi University Medical Faculty Hospital , Eskisehir , Turkey., Baslar Z; h Istanbul University Cerrahpasa Medical Faculty , Istanbul , Turkey., Ozbek U; i Institute of Experimental Medicine (DETAE) , Istanbul University , Istanbul , Turkey., Sonmez M; j Department of Internal Medicine , Karadeniz Technical University Medical Faculty , Trabzon , Turkey., Aydin D; k Okmeydani Training and Research Hospital , Istanbul , Turkey., Pehlivan M; l Department of Internal Medicine , Gaziantep University Medical Faculty , Gaziantep , Turkey., Undar B; m Department of Internal Medicine , Dokuz Eylul University Medical Faculty , Izmir , Turkey., Dagdas S; n Department of Internal Medicine , Ankara Numune Training and Research Hospital , Ankara , Turkey., Ayyildiz O; o Medical Faculty Hospital, Department of Internal Medicine , Dicle University , Diyarbakir , Turkey., Akkaynak DZ; p Novartis Pharmaceuticals Corporation , Istanbul , Turkey., Dag IM; p Novartis Pharmaceuticals Corporation , Istanbul , Turkey., Ilhan O; q Ankara University School of Medicine , Ankara , Turkey.
Publikováno v:
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2016 Oct; Vol. 17 (14), pp. 1851-8. Date of Electronic Publication: 2016 Aug 18.